GCP
LLY icon

Garda Capital Partners’s Eli Lilly LLY Stock Holding History

Garda Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-600
Closed -$467K – 485
2024
Q1 		$467K Buy
+600
New +$427K 0.02% 337
2023
Q1 		– Sell
-3,500
Closed -$1.28M – 416
2022
Q4 		$1.28M Buy
+3,500
New +$1.24M 0.07% 290

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Garda Capital Partners's LLY Position: Q2 2024 in Review

Garda Capital Partners sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 529 shares — an estimated $423K sold.

Garda Capital Partners first reported a position in LLY in Q1 2024 and held it in 1 quarter. The position peaked at $412K in Q1 2024. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Garda Capital Partners reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Garda Capital Partners sold 529 Eli Lilly shares in Q2 2024, an estimated $423K.
  • Garda Capital Partners first reported a position in Eli Lilly in Q1 2024 and held it in 1 quarter.
  • Garda Capital Partners's Eli Lilly position peaked at $412K in Q1 2024.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Garda Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.